# Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity

> **NCT02760901** · PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 52 (actual)

## Conditions studied

- Cisplatin Nephrotoxicity

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Acetylcysteine
- **DRUG:** Mannitol
- **DRUG:** saline
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02760901
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2015-10
- **Final completion:** 2016-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02760901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02760901, "Evaluation of the Effect of Acetazolamide, Mannitol and N-acetylcysteine on Cisplatin-Induced Nephrotoxicity". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02760901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*